Additional early-stage research and drug discovery news in brief, from: Enzolytics, Evaxion Biotech, Hoth Therapeutics, Lineage Cell Therapeutics, Lixte Biotechnology Holdings, Pantherna Therapeutics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Dariohealth, Dexcom, Guardant, Isoray, Paragonix, Perspective Therapeutics, RBC Medical Innovations, Sequana, Sterling Medical, Titan Medical, Viewpoint Molecular.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Ankyra, Eumentis, Inmune, J&J, Merck & Co., Nectin, Thermo, Wellmarker.

Additional early-stage research and drug discovery news in brief, from: Revelation Biosciences.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arima, Avania, Carestream, Cytek, Imperative Care, Kandu Health, Nec, Maxis, Newtopia, Medtronic Canada, Pierian, Rhythm Management Group.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Carsgen, Cidara, Healion, Qurient, Roche, TB Alliance, Tonix, Wuxi XDC, Ymmunobio.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AAHI, Actinium, Adcanz, Alvotech, Atreca, Atyr, Bioasis, BMY, CKD, Dragonfly, Indivior, Kyorin, Merck & Co., Midatech, Movantik Acquisition, Nabriva, Omeros, Opiant, Rayner, Redhill, Rubedo, Sensei, Xencor.

Additional early-stage research and drug discovery news in brief, from: Artificial Cell Technologies.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clarimed, Harvey Medical, Isoray, Viewpoint Molecular Targeting.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Defence, Merck & Co., Moderna, Personalis, Qurient, Pharmather, Revive.